Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 8Hematopoietic and Lymphatic System Neoplasm 7Neoplasms 5Lung Neoplasms 5Malignant Solid Neoplasm 4Colorectal Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Hematologic Neoplasms 3Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Adenocarcinoma, Follicular 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Smoking Cessation 1Sarcoma 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Reactive × Interviews as Topic × 90 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡